Stay updated on Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial
Sign up to get notified when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.

Latest updates to the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page
- Check6 days agoChange DetectedThe page now shows a new revision tag v3.6.3, replacing the previous v3.6.2. This indicates a small update to the page's metadata/versioning without changes to the study data or visible content.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2. This indicates a newer version of the page rendering, typically reflecting small maintenance updates to metadata or formatting.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedNew navigation/help sections were added and the Intervention/Treatment header was standardized (Intervention / Treatment to Intervention/Treatment), and the Revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check35 days agoChange DetectedThe footer now displays Revision: v3.5.5 instead of Revision: v3.5.4, indicating a small page/version update. This change is metadata-related and does not modify the study information or user workflow.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision tag 'Revision: v3.5.4' was added and the previous tag 'Revision: v3.5.3' was removed. This indicates a routine platform update to the page rather than changes to trial content.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3, indicating a minor page update or patch.SummaryDifference0.1%

Stay in the know with updates to Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.